Unlike genomic inactivation, TP53 in the human setting may be functionally suppressed through MCPyV sTAg-mediated upregulation of MDM2, further supporting the follicular genesis of MCPyV-positive MCC. Here, TP53 is linked to Merkel cell skin cancer.